The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMitchells & Butlers Regulatory News (MAB)

Share Price Information for Mitchells & Butlers (MAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 297.50
Bid: 297.50
Ask: 298.50
Change: -3.50 (-1.16%)
Spread: 1.00 (0.336%)
Open: 308.50
High: 308.50
Low: 296.00
Prev. Close: 301.00
MAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 Mitchells & Butlers Plc

29 Sep 2011 07:44

RNS Number : 1712P
Nomura International PLC (EPT)
29 September 2011
 



FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nomura International Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Mitchells & Butlers Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Mitchells & Butlers Plc

(d) Date position held/dealing undertaken:

28 September 2011

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

NO

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

8 13/24p ordinary shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

200,115

0.049%

119,734

0.029%

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

200,115

0.049%

119,734

0.029%

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Ordinary Shares

Purchase

745

2.416

Ordinary Shares

Purchase

1,986

2.418

Ordinary Shares

Purchase

11,389

2.420

Ordinary Shares

Purchase

2,032

2.421

Ordinary Shares

Purchase

1,966

2.422

Ordinary Shares

Purchase

1,416

2.423

Ordinary Shares

Purchase

4,431

2.424

Ordinary Shares

Purchase

2,698

2.425

Ordinary Shares

Purchase

4,865

2.426

Ordinary Shares

Purchase

23

2.427

Ordinary Shares

Purchase

2,921

2.428

Ordinary Shares

Purchase

5,692

2.429

Ordinary Shares

Purchase

10,719

2.430

Ordinary Shares

Purchase

5,472

2.431

Ordinary Shares

Purchase

2,151

2.432

Ordinary Shares

Purchase

4,646

2.438

Ordinary Shares

Purchase

3,902

2.439

Ordinary Shares

Purchase

65,813

2.440

Ordinary Shares

Purchase

716

2.442

Ordinary Shares

Purchase

1,045

2.443

Ordinary Shares

Purchase

988

2.444

Ordinary Shares

Purchase

3,093

2.446

Ordinary Shares

Purchase

4,696

2.448

Ordinary Shares

Purchase

579

2.449

Ordinary Shares

Purchase

1,338

2.450

Ordinary Shares

Purchase

1,040

2.453

Ordinary Shares

Purchase

2,681

2.454

Ordinary Shares

Purchase

488

2.455

Ordinary Shares

Purchase

679

2.458

Ordinary Shares

Purchase

984

2.459

Ordinary Shares

Purchase

1,040

2.460

Ordinary Shares

Purchase

5,196

2.461

Ordinary Shares

Purchase

1,122

2.461

Ordinary Shares

Purchase

6,418

2.462

Ordinary Shares

Purchase

832

2.465

Ordinary Shares

Purchase

47

2.466

Ordinary Shares

Sale

325

2.417

Ordinary Shares

Sale

7,228

2.420

Ordinary Shares

Sale

1,802

2.420

Ordinary Shares

Sale

811

2.421

Ordinary Shares

Sale

2,153

2.422

Ordinary Shares

Sale

8,798

2.423

Ordinary Shares

Sale

3,550

2.424

Ordinary Shares

Sale

424

2.425

Ordinary Shares

Sale

534

2.426

Ordinary Shares

Sale

1,280

2.427

Ordinary Shares

Sale

4,999

2.429

Ordinary Shares

Sale

6,832

2.430

Ordinary Shares

Sale

2,474

2.431

Ordinary Shares

Sale

380

2.432

Ordinary Shares

Sale

1,188

2.435

Ordinary Shares

Sale

374

2.436

Ordinary Shares

Sale

69,154

2.439

Ordinary Shares

Sale

1,997

2.440

Ordinary Shares

Sale

372

2.443

Ordinary Shares

Sale

1,322

2.444

Ordinary Shares

Sale

4,194

2.445

Ordinary Shares

Sale

355

2.446

Ordinary Shares

Sale

1,986

2.448

Ordinary Shares

Sale

2,296

2.449

Ordinary Shares

Sale

3,655

2.450

Ordinary Shares

Sale

2,171

2.453

Ordinary Shares

Sale

2,416

2.458

Ordinary Shares

Sale

2,879

2.459

Ordinary Shares

Sale

2,616

2.460

Ordinary Shares

Sale

1,299

2.461

Ordinary Shares

Sale

2,412

2.462

Ordinary Shares

Sale

942

2.463

Ordinary Shares

Sale

3,812

2.466

 

TOTAL BUY - 165,849

TOTAL SELL - 147,030

 

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

29 September 2011

Contact name:

Kyere Tabiri

Telephone number:

020 7102 1267

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEODKCDQABKKNCB
Date   Source Headline
28th May 20242:30 pmRNSDirector/PDMR Shareholding
22nd May 20247:00 amRNSHalf Year Results
17th May 202410:00 amRNSNotice of Half Year Results
30th Apr 202411:00 amRNSTotal Voting Rights
29th Apr 20243:08 pmRNSDirector/PDMR Shareholding
2nd Apr 20243:45 pmRNSDirector/PDMR Shareholding
2nd Apr 20241:30 pmRNSBlock listing Interim Review
28th Mar 20241:00 pmRNSTotal Voting Rights
4th Mar 202412:30 pmRNSDirector/PDMR Shareholding
29th Feb 20242:00 pmRNSTotal Voting Rights
5th Feb 20243:30 pmRNSDirector/PDMR Shareholding
31st Jan 20242:21 pmRNSDirector/PDMR Shareholding
31st Jan 202410:00 amRNSTotal Voting Rights
23rd Jan 202412:16 pmRNSResult of Annual General Meeting
17th Jan 20247:00 amRNSFirst Quarter Trading Update
15th Jan 20241:00 pmRNSNotice of First Quarter Trading Update
8th Jan 20242:00 pmRNSDirector/PDMR Shareholding
2nd Jan 20242:00 pmRNSTotal Voting Rights
22nd Dec 20239:36 amRNSDirectorate Declaration
20th Dec 202312:00 pmRNSAnnual Report 2023
14th Dec 20232:30 pmRNSDirector/PDMR Shareholding
11th Dec 20234:35 pmRNSDirector/PDMR Shareholding
8th Dec 202311:30 amRNSDirector/PDMR Shareholding
7th Dec 202310:30 amRNSDirector/PDMR Shareholding
30th Nov 202311:30 amRNSTotal Voting Rights
30th Nov 20237:00 amRNSFULL YEAR RESULTS
24th Nov 202312:00 pmRNSNotice of Final Results
14th Nov 202310:45 amRNSDirector/PDMR Shareholding
13th Nov 20232:30 pmRNSDirector/PDMR Shareholding
31st Oct 20231:00 pmRNSTotal Voting Rights
31st Oct 202310:00 amRNSDirectorate Declaration
16th Oct 20232:00 pmRNSDirector/PDMR Shareholding
9th Oct 20233:46 pmRNSListing Application
2nd Oct 20232:30 pmRNSBlock listing Interim Review
28th Sep 20237:00 amRNSFourth Quarter Trading Update
25th Sep 202312:00 pmRNSNotice of Fourth Quarter Trading Statement
18th Sep 20233:00 pmRNSDirector/PDMR Shareholding
15th Sep 20232:20 pmRNSDirector/PDMR Shareholding
15th Sep 20232:15 pmRNSDirector/PDMR Shareholding
31st Aug 20232:32 pmRNSTotal Voting Rights
21st Aug 20232:30 pmRNSDirector/PDMR Shareholding
31st Jul 20231:14 pmRNSTotal Voting Rights
27th Jul 20237:00 amRNSThird Quarter Trading Update
24th Jul 20232:50 pmRNSDirector/PDMR Shareholding
21st Jul 202312:06 pmRNSNotice of Third Quarter Trading Update
30th Jun 202310:30 amRNSTotal Voting Rights
26th Jun 202311:15 amRNSDirector/PDMR Shareholding
31st May 20233:15 pmRNSTotal Voting Rights
30th May 20233:00 pmRNSDirector/PDMR Shareholding
17th May 20237:00 amRNSHalf Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.